Textron Work in process increased by 7.7% to $2.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.9%, from $1.95B to $2.23B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 7.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.66B | $1.71B | $1.74B | $1.55B | $1.69B | $1.71B | $1.75B | $1.54B | $1.75B | $1.82B | $1.88B | $1.74B | $1.98B | $2.00B | $1.96B | $1.77B | $1.95B | $2.03B | $2.17B | $2.07B | $2.23B |
| QoQ Change | — | +2.9% | +1.7% | -11.1% | +8.9% | +1.1% | +2.9% | -12.2% | +13.8% | +3.8% | +3.1% | -7.5% | +13.8% | +1.0% | -1.8% | -9.8% | +10.5% | +3.7% | +7.2% | -4.9% | +7.7% |
| YoY Change | — | — | — | — | +1.4% | -0.4% | +0.7% | -0.5% | +4.0% | +6.7% | +7.0% | +12.7% | +12.7% | +9.7% | +4.5% | +1.9% | -1.1% | +1.5% | +10.8% | +16.7% | +13.9% |
| % of Inventories | 44.9% | 46.7% | 47.4% | 44.6% | 46.0% | 45.6% | 46.0% | 43.4% | 44.6% | 44.3% | 44.6% | 44.4% | 46.3% | 45.6% | 44.5% | 43.5% | 45.8% | 46.7% | 48.7% | 48.3% | 48.8% |
| Share Change | — | +1.8pp | +0.7pp | -2.8pp | +1.4pp | -0.4pp | +0.4pp | -2.6pp | +1.2pp | -0.3pp | +0.3pp | -0.3pp | +2.0pp | -0.7pp | -1.1pp | -1.0pp | +2.3pp | +0.9pp | +2.0pp | -0.4pp | +0.5pp |